Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 7,793 | 7,098 | 8,144 | 8,205 | 6,595 |
| Operating Income | -7,793 | -7,098 | -8,144 | -8,205 | -6,595 |
| Other Income | -2,037 | 817 | 653 | 194 | -77 |
| Pre-tax Income | -9,830 | -6,281 | -7,491 | -8,011 | -6,672 |
| Net Income Continuous | -9,830 | -6,281 | -7,491 | -8,011 | -6,672 |
| Net Income | $-9,830 | $-6,281 | $-7,491 | $-8,011 | $-6,672 |
| EPS Basic Total Ops | -0.08 | -0.05 | -0.06 | -0.06 | -0.05 |
| EPS Basic Continuous Ops | -0.08 | -0.05 | -0.06 | -0.06 | -0.05 |
| EPS Diluted Total Ops | -0.08 | -0.05 | -0.06 | -0.06 | -0.05 |
| EPS Diluted Continuous Ops | -0.08 | -0.05 | -0.06 | -0.06 | -0.05 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.05 | -0.06 | -0.06 | N/A |
| EBITDA(a) | $-7,790 | $-7,095 | $-8,142 | $-8,203 | $-6,593 |